Clinical trial
Autologous Nebulized Platelet Lysate for Post COVID-19 Syndrome
NCT04487691 is registered in ClinicalTrials.gov with Regenexx, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Autologous Nebulized Platelet Lysate for Post COVID-19 Syndrome
- Lead sponsor
- Regenexx, LLC
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- December 8, 2020
- Completion date
- June 15, 2021
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19